Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Harvard Business School
Mallinckrodt
Healthtrust
US Department of Justice
Argus Health
Queensland Health
Cantor Fitzgerald
McKinsey

Generated: April 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: aztreonam

« Back to Dashboard

aztreonam

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Gilead CAYSTON aztreonam FOR SOLUTION;INHALATION 050814 NDA Gilead Sciences, Inc. N 61958-0901-1
Bristol Myers Squibb AZACTAM aztreonam INJECTABLE;INJECTION 050580 NDA E.R. Squibb & Sons, L.L.C. N 0003-2560-16
Bristol Myers Squibb AZACTAM aztreonam INJECTABLE;INJECTION 050580 NDA E.R. Squibb & Sons, L.L.C. N 0003-2570-16
Bristol Myers Squibb AZACTAM IN PLASTIC CONTAINER aztreonam INJECTABLE;INJECTION 050632 NDA E.R. Squibb & Sons, L.L.C. N 0003-2230-11
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
UBS
Healthtrust
Deloitte
Citi
Farmers Insurance
QuintilesIMS
US Army